- Trials with a EudraCT protocol (1,572)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1,572 result(s) found for: Blood volume.
Displaying page 1 of 79.
EudraCT Number: 2013-004446-42 | Sponsor Protocol Number: AIR | Start Date*: 2014-02-09 |
Sponsor Name:Skåne University Hospital | ||
Full Title: THE IMPORTANCE OF ALBUMIN INFUSION RATE FOR PLASMA VOLUME EXPANSION FOLLOWING MAJOR ABDOMINAL SURGERY | ||
Medical condition: Post operative patients who have been subjected to either a non-emergant Whipple operation or major gynecological cancer surgery ( including resection of ovaries, uterus, adnexa, oment and lymph ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002455-26 | Sponsor Protocol Number: IRON-CMR | Start Date*: 2014-09-20 |
Sponsor Name:Karolinska Institute | ||
Full Title: The use of intravenous Iron oxide as a contrast agent for cardiac magnetic resonance imaging. | ||
Medical condition: Cardiovascular diseases: Acute myocardial infarction, chronic myocardial infarction, myocardial ischemia, myocarditis, diffuse myocardial fibrosis. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-004175-22 | Sponsor Protocol Number: HC-G-H-0803 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:B. Braun Melsungen AG | |||||||||||||
Full Title: PROSPECTIVE, CONTROLLED, DOUBLE-BLIND, RANDOMIZED MULTICENTRIC STUDY ON THE EFFICACY AND SAFETY OF A TARGET CONTROLLED PLASMA VOLUME REPLACEMENT THERAPY WITH A HYPER-ONCOTIC BALANCED HES 130/0.42... | |||||||||||||
Medical condition: Intraoperative plasma volume replacement requirement in elective surgery of the pancreatic head (pylorus preserving pancreatic-duodenectomy, PPPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004512-11 | Sponsor Protocol Number: FJD-VITDAMI-14-01 | Start Date*: 2015-08-06 |
Sponsor Name:INSTITUTO DE INVESTIGACION SANITARIA FJD | ||
Full Title: Multicenter, randomized, double-blind, placebo-controlled study to evaluate the effect of vitamin D on ventricular remodeling in patients with acute myocardial infarction: Test VITDAMI (Vitamin D i... | ||
Medical condition: Acute myocardial infarction with ST segment elevation anterior | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002096-16 | Sponsor Protocol Number: 01/04 | Start Date*: 2005-05-23 |
Sponsor Name:Universitätskinderklinik Innsbruck | ||
Full Title: Effect of plasma volume expansion with hydroxy-ethyl-starch (HES) 130/0.4 or crystalloids on interstitial fluid accumulation and blood pressure in newborn infants with arterial hypotension | ||
Medical condition: Arterial hypotension | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-008597-31 | Sponsor Protocol Number: | Start Date*: 2010-08-17 |
Sponsor Name:Malmoe University Hospital | ||
Full Title: Comparative study to evaluate the effects of racemic ketamin versus s-ketamine on cerebral blood flow, blood volume and metabolism | ||
Medical condition: Racemic ketamine is used for sedation, analgesia and anesthesia to patients in various forms of circulatory compromise ie shock. The enantiomere S-ketamine has not been compared regarding cerebral ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002162-30 | Sponsor Protocol Number: HC-G-H-1504 | Start Date*: 2017-04-12 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution in patients u... | |||||||||||||
Medical condition: Hypovolaemia due to acute blood loss in elective abdominal surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) NL (Completed) ES (Restarted) FR (Ongoing) AT (Completed) HR (Completed) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000867-27 | Sponsor Protocol Number: HDPET | Start Date*: 2006-05-04 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Gated 13N-NH3 PET before and during hemodialysis for the assessment of changes in myocardial perfusion, volumes and output of the left ventricle | ||
Medical condition: Hemodialysis patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002176-27 | Sponsor Protocol Number: HC-G-H-1505 | Start Date*: 2017-08-30 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Pragmatic, prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of a 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution ... | |||||||||||||
Medical condition: Hypovolaemia due to acute blood loss in trauma surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) CZ (Completed) NL (Completed) ES (Restarted) FR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000748-24 | Sponsor Protocol Number: -- | Start Date*: 2018-08-09 |
Sponsor Name:VUmc | ||
Full Title: Partial neuromuscular blockade to facilitate lung and diaphragm protective mechanical ventilation in ICU patients. A randomized controlled pilot study. | ||
Medical condition: Some patients develop high respiratory drive during partially supported mechanical ventilation which is associated with lung and diaphragm injury and worse clinical outcome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-008354-23 | Sponsor Protocol Number: ECAL-CCPB-08-07 | Start Date*: 2009-04-30 |
Sponsor Name:Cubist Pharmaceuticals,INC | ||
Full Title: CONSERVTM – 2 (Clinical Outcomes and Safety Trial to Investigate Ecallantide’s Effect on Reducing Surgical Blood Loss Volume) – A Phase 2 Randomized Double-Blind Active-Controlled Study in Subjects... | ||
Medical condition: Reduction of blood loss in subjects exposed to CPB during cardiac surgery at high risk for bleeding | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: PL (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-004192-41 | Sponsor Protocol Number: A0221109 | Start Date*: 2020-09-03 |
Sponsor Name:Pfizer | ||
Full Title: LONG-TERM EXTENSION STUDY TO EVALUATE THE SAFETY OF FESOTERODINE IN JAPANESE PEDIATRIC SUBJECTS WITH SYMPTOMS OF DETRUSOR OVERACTIVITY ASSOCIATED WITH A NEUROLOGICAL CONDITION (NEUROGENIC DETRUSOR ... | ||
Medical condition: Urinary Bladder, Neurogenic | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2014-005577-36 | Sponsor Protocol Number: neopopgen_v1.0 | Start Date*: 2015-04-02 |
Sponsor Name:Teijo Saari | ||
Full Title: Individualising propofol and oxycodone therapy in neonates using pharmacogenomic profiling, population based modeling and simulations. | ||
Medical condition: Neonates, who need to be intubated and ventilated with a ventilator. | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005040-85 | Sponsor Protocol Number: HaHes | Start Date*: 2006-03-17 |
Sponsor Name:Department of Anesthesia, Div. of Cardiothoracic and Vascular Anesthesia, Medical University Vienna | ||
Full Title: Comparison of Albumin 5%, Hydroxyethyl Starch 130/0.4 (6%) and Ringer Lactate for volume replacement during cardiac surgery | ||
Medical condition: Intensive care patients after cardiac surgery requiring volume therapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-003260-32 | Sponsor Protocol Number: 13090 | Start Date*: 2013-12-04 |
Sponsor Name: | ||
Full Title: The Effects of Isovolumetric and Isoeffective Infusions of Colloid Versus Crystalloid on Renal Blood Flow and Cardiac Output | ||
Medical condition: Anaesthesia | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-013159-31 | Sponsor Protocol Number: CS/2009/3292 | Start Date*: 2010-02-25 |
Sponsor Name:University Hospitals Bristol NHS Foundation Trust | ||
Full Title: Preoperative volume replacement vs. usual care in diabetic patients having CABG surgery: a randomised controlled trial | ||
Medical condition: Coronary artery bypass grafting in diabetic patients | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-003398-24 | Sponsor Protocol Number: FP2012/01 | Start Date*: 2012-10-29 | ||||||||||||||||
Sponsor Name:FUNDACIÓ PUIGVERT | ||||||||||||||||||
Full Title: Randomized clinical trial to compare the effect of mannitol and hydroelectrolytic solutions as kidney function protector, in partial laparoscopic nephrectomies (MANCOL Study) | ||||||||||||||||||
Medical condition: partial laparoscopic nephrectomy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002122-30 | Sponsor Protocol Number: 1978 | Start Date*: 2007-09-14 | |||||||||||||||||||||
Sponsor Name:Medical University Vienna Division of Anesthesie and Pain Management | |||||||||||||||||||||||
Full Title: The effect of different solvents of HES preparations on coagulation and platelet function (Effekt der Trägerlösung von HES Präparaten auf Blutgerinnung und Thrombozytenfunktion) | |||||||||||||||||||||||
Medical condition: treatment and prophylaxis of acute hypovolaemia and shock acute normovolaemic haemodilution | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||||||||||||
Trial protocol: AT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-002661-36 | Sponsor Protocol Number: 15039DB-SW | Start Date*: 2016-03-10 |
Sponsor Name:Belfast Health and Social Care Trust | ||
Full Title: Single centre randomised controlled trial to assess the effect of the addition of twenty-four hours of oral tranexamic acid post-operatively to a single intra-operative intravenous dose of tranexam... | ||
Medical condition: Osteoarthritic patients who require hip or knee arthroplasty | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-021983-14 | Sponsor Protocol Number: MLK002 | Start Date*: 2010-09-23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:UZ Gasthuisberg | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A randomized placebo-controlled double blind study to treat BOS. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: -Mortality at 1 and 2 year post diagnosis of BOS -Infection rate during BOS -Evolution of pulmonary function after diagnosis of BOS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
